The Economic Times

Centre to bar drugmakers from selling mislabelled, fraudulently approved products under new provisions

New rules will bar drugmakers from selling products if false information was provided. The Union Ministry of Health & Family Welfare has amended the Drugs Rules, 1945. This adds accountability for drug manufacturers and distributors operating in the country. The Licensing Authority can now debar entities from filing future applications. This amendment aims to deter misconduct and ensure reliable drug approval evidence.